Skip to main content Help with accessibility Skip to main navigation

ALIROCUMAB injection (Praluent®▼)

CCG Approval Status:

Date Added: 07 - Jul - 2016
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of ALIROCUMAB (Praluent®▼) by specialists only, for treating primary hypercholesterolaemia and mixed dyslipidaemia in accordance with NICE TA393.